Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) EBT Margin (2022 - 2025)

Century Therapeutics (IPSC) has disclosed EBT Margin for 4 consecutive years, with 70.13% as the latest value for Q1 2025.

  • Quarterly EBT Margin rose 335212.0% to 70.13% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 8.83% through Dec 2025, down 889.0% year-over-year, with the annual reading at 8.84% for FY2025, 891.0% down from the prior year.
  • EBT Margin for Q1 2025 was 70.13% at Century Therapeutics, down from 2168.32% in the prior quarter.
  • The five-year high for EBT Margin was 2168.32% in Q4 2024, with the low at 32667.68% in Q2 2023.
  • Average EBT Margin over 4 years is 7184.93%, with a median of 3544.14% recorded in 2022.
  • The sharpest move saw EBT Margin plummeted -3044920bps in 2023, then surged 2862293bps in 2024.
  • Over 4 years, EBT Margin stood at 6074.86% in 2022, then tumbled by -147bps to 15025.0% in 2023, then surged by 114bps to 2168.32% in 2024, then tumbled by -97bps to 70.13% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 70.13%, 2168.32%, and 3948.67% for Q1 2025, Q4 2024, and Q3 2024 respectively.